[Medical treatment of voiding problems in men].
Lower Urinary Tract Symptoms (LUTS) e.g. in prostatic infravesical obstruction and symptoms of overactive bladder (OAB) in men can be treated effectively with drugs. The current evidence for use of alpha-adrenergic blocking agents, 5-alpha-reductase inhibitors, combination therapy and antimuscarinic agents is reviewed with suggestions for follow-up. The increasing use of alpha-blockers, 5-alpha-reductase inhibitors, or both for symptomatic BPH has led to a significant decrease in the number of operations for BPH in the last decade. Bothersome nocturia due to nocturnal polyuria may be resolved by the administration of a loop-diuretic in the late afternoon.
Andersen
Jens Thorup
JT
Roskilde Sygehus, Urologisk Afdeling D, Herlev Hospital, Urologisk Afdeling H.
Nordling
Jørgen
J
Walter
Steen
S
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D050034:Antidiuretic Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D011469:Prostatic Diseases / Q000188:drug therapy*; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014555:Urination Disorders / Q000188:drug therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D050034:Antidiuretic Agents; D004232:Diuretics; D004791:Enzyme Inhibitors; D018727:Muscarinic Antagonists